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1. Introduction 
According to reports of the WHO and IDF, the number of adults living with diabetes 
has more than doubled in the past two decades. At the moment, nearly half a billion people 
suffer from diabetes in the world and the rise of the prevalence of the disease is still expected 
in the upcoming years. In addition to the rapid spread, another worrisome feature is that diabetes 
is affecting the younger generation, not only young adults but also adolescents and children. 
The most common type of diabetes is type 2 diabetes mellitus (T2DM), which accounts for 
more than 90% of all cases of diabetes. To the best of our knowledge, it is not possible to cure 
T2DM, the doctors try to keep the blood glucose concentration within the normal range during 
the medicinal treatment with oral antihyperglycemic agents. However, the available medicines 
are often ineffective and possess many side effects, therefore, intensive research has been 
carried out to develop new therapeutic options. A new possible treatment may be to reduce the 
elevated hepatic glucose production, which can be achieved by the inhibition of glycogen 
phosphorylase (GP, the key enzyme of glycogenolysis). 
In our research group the preparation of new glucose analogue glycogen phosphorylase 
inhibitors has been investigated for more than 20 years. Several types of compounds proved to 
be efficient inhibitors: N-acyl-N’-β-D-glucopyranosyl ureas, C-β-D-glucopyranosyl 
heterocycles, glucopyranosylidene-spiro-heterocycles. I joined this research field during my 
PhD work and my goal was the synthesis of five membered spiro-glucopyranosylidene-
heterocycles and C-glucopyranosyl 1,2,4-triazoles. 
Glucopyranosylidene-spiro-hydantoin (A, X = O) and thiohydantoin (A, X = S) were 
active against GP in the low micromolar concentration range (Scheme 1). According to the X-
ray crystallography of the enzyme-inhibitor complexes, the importance of the H-bond donor β-
NH groups, as well as the presence of the α-carbonyl groups was revealed. In the case of the 2-
naphthyl substituted glucopyranosylidene-spiro-oxathiazoles (B, X = S) and isoxazolines (B, X 
= CH2) the Ki values are lower by an order of magnitude. The large and properly oriented 
aromatic moieties of the molecules that form interactions with the β-channel of the enzyme 
were accounted for the strong binding of these compounds. Based on these structure‒activity 
relationships, we envisaged the improvement of these molecules and the synthesis of new 
spirocycles that unify the properties of the best inhibitors. The target compounds (C) should 
have a rigid spirobicyclic scaffold in which the carbonyl group is oriented at the α-position and 
a large aromatic group must be present on the spirocycle. We planned to examine the role of 
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the X group, in the case when the heterocycle bears a H-bridge donor NH or non-hydrogen 
bond donor sulphur atom in this position.  
 
 
Scheme 1: Selected spirobicyclic inhibitors (A, B), their inhibition constants against rabbit 
muscle GP enzyme (RMGPb) and the target compounds (C) 
 
The possible synthetic pathways for the preparation of C-glycopyranosyl 1,2,4-triazoles 
were studied earlier in our research group. As a continuation of our efforts in these syntheses, 
the preparation of trisubstituted 1,2,4-triazoles has been investigated. From the three possible 
isomeric structures (Scheme 2) the synthetic methods of 3-glycosyl-4,5-disubstituted-triazoles 
(D) and 5-glycosyl-1,3-disubstituted-triazoles (E) have already been elaborated. Consequently, 
we planned to prepare 3-β-D-glucopyranosyl-1,5-disubstituted-1,2,4-triazoles (F). 
 
 
Scheme 2: Possible isomeric forms of trisubstituted C-glycopyranosyl 1,2,4-triazoles 
 
2. Methods 
In the course of the synthetic work, macro-, semi-micro- and micro-scale methods of 
the modern preparative organic chemistry were applied. Reactions were monitored by thin-
layer chromatography. Products of the reactions were purified by column chromatography 
and/or crystallization. New compounds were characterized by their physical properties (melting 
point, optical rotation, elemental analysis) and their structures were elucidated by one or two-
dimensional 1H and 13C NMR methods, as well as mass spectrometry. 
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3. Results 
3.1. A new method was developed for the preparation of O-acyl protected (1’R)-1’,5’-
anhydro-D-glucitol-spiro-[1’,5]-2-arylthiazolin-4-ones. Novel alcohol and water addition 
products were discovered during the experiments towards to deprotection of the acyl 
protected spiro derivatives.  
The reaction of C-(2,3,4,6-tetra-O-benzoyl-1-bromo-1-deoxy-β-D-glucopyranosyl) 
formamide (99) with aromatic thioamides by heating in inert solvents provided 
glucopyranosylidene-spiro-thiazolinone derivatives (Scheme 3, 98, 101, 102, 107). 
Optimization of reaction conditions were performed and shorter reaction time was achieved 
with the application of microwave-assisted heating instead of oil bath and the yields improved, 
too (e.g. the yield of thiazolinone 98 raised from 33 % to 53 %). The configuration of the 
anomeric centre was proven by the measurement of three bond coupling constant (in the case 
of thiazolinone 98 3JH2,CO = 6.0 Hz). 
 
 
Scheme 3: Synthesis of perbenzoylated 2-aryl-glucopyranosylidene-spiro-thiazolin-4-ones  
 
Attempts to remove the benzoyl protecting groups under a series of transesterification 
conditions or under basic hydrolysis conditions proved unsuccessful. After this, the use of the 
more readily removable O-acetyl protecting groups was envisaged. Experiments were carried 
out to facilitate the O-deacetylation of compound 114 and we could isolate products in two 
cases (Scheme 4). The use of KHSO4 resulted in a moderate yield of 115 with the C-2’ O-acetyl 
group remaining intact in the molecule and the addition of the solvent methanol molecule also 
occurred to the C=N bond of thiazolinone ring. Removal of the acetyl protecting groups with 
LiOH in methanolic solution provided the expected unprotected sugar (108) as a mixture with 
the methanol addition product (116).  
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Scheme 4: Preparation of (1’R)-2’,3’,4’,6’-tetra-O-acetyl-1’,5’-anhydro-D-glucitol-spiro-[1’,5]- 
2-phenylthiazolin-4-one and experiments towards its deprotection  
 
The presence of MeOH addition products 115 and 116 in the deacetylation mixtures 
prompted us to investigate the reaction of 98 and 114 with MeOH and EtOH without any other 
additive (Table 1, entries 1-4). It turned out that both alcohols added to the thiazolinone moiety 
to furnish 117-120 as the major stereoisomers. These preponderant diastereomers were formed 
although the attack of the alcohol could have been expected from both sides of the planar 
thiazolinone ring. This observation may be explained by a steric hindrance of the C-2 centre by 
the 2’-OAc or 2’-OBz groups facilitating the addition reaction from the opposite side. This 
addition reaction proved to be reversible, since by heating 117 (at 80 °C) or 119 (at 60 °C) in 
toluene thiazolinones 98 and 114 were recovered, respectively. The addition of water was also 
tested with 114 (entry 5) and the formation of 121 was observed in a mixture with the starting 
compound. 
 
Table 1: Addition of alcohols and water onto spiro-thiazolinones 98 
and 114  
 
Entry Starting compound R’ group Product 
1. 98 Me 117 
2. Et 118 
3. 114 Me 119 
4. Et 120 
5. H 121a 
aPartial addition (114:121 ~ 1:0,4 in the case of toluene-water system; 
114:121 ~ 1:0,7 in the case of dioxane-water system) 
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Since no NMR methods seemed suitable to determine the configuration of C-2 of the addition 
products 115–121, ECD measurements and TDDFT-ECD calculations were performed. Sándor 
Balázs Király, Attila Mándi and Tibor Kurtán provided us help to carry out these studies This 
method was extended to compound 114 to determine the absolute configuration of C-1’ spiro 
centre in order to confirm the previously obtained NMR results independently.  
 
3.2. C-(1-Arylideneamino-2,3,4,6-tetra-O-benzoyl-1-deoxy-D-glucopyranosyl) 
formamides were prepared in both anomeric configurations and a novel ring-closure 
method was developed for the synthesis of (1’R)- and (1’S)-1’,5’-anhydro-D-glucitol-
spiro-[1’,5]-2-arylimidazoline-4-ones.  
C-(1-Amino-2,3,4,6-tetra-O-benzoyl-1-deoxy-β-D-glucopyranosyl)formamide (122) was 
reacted with benzaldehyde in an acid catalyzed condensation reaction and the anomeric mixture 
of the corresponding Schiff bases were formed (129, 133, Scheme 5 method a). We were not 
able to separate these compounds due to their identical chromatographic mobility so the 
transformation was performed by using an aminocatalytic method (Scheme 5 method b) to 
afford the expected C-(1-arylideneamino-2,3,4,6-tetra-O-benzoyl-1-deoxy-β-D-glucopyra-
nosyl)formamides (129-132) in good yields.  
 
 
Scheme 5: Transformation of C-(1-amino-2,3,4,6-tetra-O-benzoyl-1-deoxy-β-D-
glucopyranosyl)formamide into the corresponding arylideneamino derivatives 
 
The epimeric compounds were prepared from C-(1-azido-2,3,4,6-tetra-O-benzoyl-1-
deoxy-α-D-glucopyranosyl)formamide (134). In this case, the arylideneamino function was 
formed by an aza-Wittig reaction (Scheme 6). In the first step of the transformation, a 
phosphazide intermediate (136) was generated, since the loss of N2 molecule did not occur 
spontaneously. Then, 136 was further reacted with aldehydes to result in the formation of 
triazene derivatives 135, 137-139. The release of nitrogen from these compounds afforded the 
Schiff bases as anomeric mixtures at room temperature. When the reaction mixtures were kept 
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at low temperatures (0-5 °C), the desired 133, 140-142 compounds were isolated in pure 
anomeric state.  
 
 
 
Scheme 6: Aza-Wittig reaction of C-(1-azido-2,3,4,6-tetra-O-benzoyl-1-deoxy-α-D-
glucopyranosyl)formamide  
 
 Several methods were tried to facilitate the intramolecular cyclization reaction of the 
imine 129 (Table 2). Heating and treatment with a Lewis acid resulted in the same unexpected 
oxazoline 143 in low yield. Decomposition was observed in basic medium. The preparation of 
the spiro-imidazolinone ring of 144 was achieved by the activation of the imine-type molecule 
with NBS. Upon addition of bases in order to neutralise the evolved HBr, the yields improved 
significantly (see Table 2, entries 5-7).  
 
Table 2: Experiments towards the ring closure of C-(2,3,4,6-tetra-O-benzoyl-1-
benzylideneamino-1-deoxy-β-D-glucopyranosyl)formamide  
 
Entry Reaction conditions Observation 
1. DMF, 160 °C, MW, 30 min 143 (24 %) 
2. m-xylene, reflux, 3 days 143 (17 %)  
3. 20 mol% BF3OEt2, CH2Cl2, rt, 3 days 143 (25 %) 
4. pyridine, reflux, 2 days Decomposition 
5. NBS (1.1 equiv.), CH2Cl2, rt, 2 days 144 (41 %)  
6. NBS (1.1 equiv.), K2CO3, CH2Cl2, rt, 2 days 144 (60 %) 
7. NBS, pyridine (1.1 equiv. – 1.1 equiv), CH2Cl2, rt, 2 days 144 (71 %) 
Observed side-product: 
 
  143 
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This procedure has not been known in the literature so far to produce similar rings. To 
understand the process of ring closure better, the reaction was followed by 1H NMR 
measurements and a mechanism was proposed for the transformation. The formation of the 
bicyclic oxazoline 143 was studied from compounds 129, 133 and 122. 
The imine-type molecules 129-133, 140-142 were reacted with NBS and pyridine (1.1 
equiv. – 1.1 equiv.) and spirocycles 144-151 were obtained in good yields (Scheme 7 and 8). 
We observed the formation of the epimeric spiro-heterocycles from the pure anomeric forms of 
the starting compounds, although only in small amounts. Imines 133, 140-142 showed 
significant anomerization during the ring closure reactions at room temperature. In the case of 
Schiff base 133, the reaction provided the expected imidazolinone 148 with 43 % yield and the 
epimer 144 with 32 % yield. Repeating the reaction at a lower temperature (0-5 °C) the 
anomerization was greatly reduced (68 % of 148 and 10 % of 144, respectively). As the last 
step, the removal of the ester protecting groups by the Zemplén procedure provided compounds 
152-159 in good yields. The separation of the products could be achieved with column 
chromatography in both steps.  
The configuration of the anomeric carbon atoms of the protected compounds was 
confirmed by NMR measurements (129: 3JH2,CO = 2.3 Hz; 133: 
3JH2,CO = 5.4 Hz; 144: 
3JH2,CO = 
2.8 Hz; 148: 3JH2,CO = 5.5 Hz). 
 
 
Scheme 7: Synthesis of (1’R)-1’,5’-anhydro-D-glucitol-spiro-[1’,5]-2-arylimidazoline-4-ones 
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Scheme 8: Preparation of (1’R)-1’,5’-anhydro-D-glucitol-spiro-[1’,5]-2-arylimidazoline-4-ones 
 
3.3. A new method for the preparation of 3-β-D-glucopyranosyl-1,5-disubstituted-1,2,4-
triazoles was elaborated and novel disubstituted 1,2,4-triazoles were synthesized. 
Extensive studies have been carried out in our research group in order to prepare C-
glycosyl 1,2,4-triazoles and my task was to synthesize 3-β-D-glucopyranosyl-1,5-disubstituted-
1,2,4-triazoles. The N-acylation of C-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl) 
thioformamide (171) was carried out smoothly with aliphatic acid chlorides to give 174-177 in 
excellent yields (Scheme 9). In stark contrast to these results, the attempts to acylate 
thioformamide 171 with aromatic acid chlorides provided glucosyl cyanide 168 as the major 
product. This phenomenon may be explained by the formation of an S-acylated derivative (173), 
which then underwent a spontaneous loss of thioacid and thus lead to the observed nitrile 168. 
 
 
Scheme 9: Acylation reaction of C-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)thioformamide 
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To facilitate the formation of 1,2,4-triazole rings, N-acyl-thioformamides 174-177 were 
reacted with hydrazine and substituted hydrazines in pyridine (Table 3). The corresponding C-
glycopyranosyl 1,2,4-triazoles (178-190) were isolated in good yields and the removal of the 
benzoyl protecting groups by NaOMe in methanol gave unprotected triazoles 191-199.  
Table 3: Synthesis of 3-β-D-glucopyranosyl-1,5-disubstituted-1,2,4-triazoles  
 
Entry 
Starting 
compound 
R R’ 
Yield (%) 
R” = Bz R” = H 
1. 174 CH3 H 178a (55) - 
2. Ph 179 (67) 191 (70) 
3. C2H4OH 180 (70) 192 (72) 
4. Ts 181a (63) - 
5. 175 AcOCH2 H 182a (92) - 
6. Ph 183 (70) 
193 (84) 
R = CH2OH 
7. C2H4OH 
184 (65) 
R = CH2OH 
194 (62) 
R = CH2OH 
8. 176 tBu H 185a (79) - 
9. Ph 186 (66) 195 (50) 
10. C2H4OH 187 (65) 196 (65) 
11. 177 Bn H 188 (75) 197 (45) 
12. Ph 189 (71) 198 (70) 
13. C2H4OH 190 (90) 199 (51) 
a Earlier in our group the compound was prepared by the reaction of N1-tosyl-C-
(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyl)formamidrazone and the 
corresponding acid chloride.  
 
In the case of the substituted hydrazines the ring closure reactions proceeded in a 
regioselective manner because of the distinctively different reactivity of the C=O and C=S 
moieties in the N-acyl-thioamides. The structure of triazole 191 was confirmed by 
measurements of nuclear Overhauser effects (NOE, Scheme 10). The spectra demonstrated the 
vicinity of the methyl protons and Ph groups, which implies that structure 191a is produced as 
the result of the reaction.  
 
Scheme 10: The possible isomeric structures of 1,2,4-triazoles 191  
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Unprecedented C-glycosyl-tri- and disubstituted-1,2,4-triazoles can be synthesized by 
the above described method. The only limitation of this synthetic pathway is that no aromatic 
substituent can be introduced in the 5-position of the triazole ring.  
 Based on a known synthetic method, novel disubstituted 1,2,4-triazoles were also 
synthesized (Table 4). The prepared molecules 210-212 are interesting with regard to the 
structure-activity relationships, however, they were not available by any of the earlier applied 
synthetic routes. The corresponding anhydro-aldonic acids 200, 202 were transformed to acid 
chlorides 201, 203 and then reacted with aromatic thioamides to give N-
glucopyranosylcarbonyl-thiocarboxamides 204-206 in good yields. The desired 1,2,4-triazole 
rings were prepared by the treatment with hydrazine hydrate. The benzoyl protected 207 was 
isolated and the protecting groups were removed by NaOMe catalyzed transesterification to 
yield 210. Triazoles 208, 209 were deprotected after the ring closure reactions in a’one-pot’ 
method with an excess of hydrazine and 5-aryl-3-(2′-amino-2′-deoxy-β-D-glucopyranosyl)-
1,2,4-triazoles 211, 212 were also isolated.  
 
Table 4: Synthesis of 5-aryl-3-(β-D-glucopyranosyl)-1,2,4-triazoles  
 
Entry Product Ar R’ R” Yield (%) 
1. 204 1-Naphthyl Bz OBz 71 
2. 205 Ph Ac NPht 82 
3. 206 2-Naphthyl Ac NPht 74 
4. 207 1-Naphthyl Bz OBz 70 
5. 208 Ph Ac NPht - 
6. 209 2-Naphthyl Ac NPht - 
7. 210* 1-Naphthyl - OH 90 
8. 211* Ph - NH2 40 
9. 212* 2-Naphthyl - NH2 68 
* Compound 210 was prepared by method d), compounds 211, 212 were 
deprotected by method e).  
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4. Enzyme kinetic studies and structure ‒ activity relationships 
The new compounds were tested against glycogen phosphorylase enzyme at the 
Department of Medical Chemistry of the University of Debrecen and at the Department of 
Biochemistry and Biotechnology of the University of Thessaly (Biopolis, 41500 Larissa, 
Greece). Rabbit muscle glycogen phosphorylase a and b forms (RMGPa and RMGPb) and the 
recombinant human liver GPa (HLGPa) were used for the enzyme kinetic measurements.  
 The glucopyranosyl-spiro-thiazolinones were not suitable for testing the inhibition 
against the enzyme. The unprotected thiazolinone derivative 108 was isolated only in a mixture 
with thiazolidinone 116 which was formed by methanol addition. Similar addition may occur 
with water during the enzymatic tests necessarily carried out under aqueous conditions, thereby 
thwarting the study of these compounds as enzyme inhibitors. 
 The inhibition constants of the spiro-imidazolinones are summarized in Table 5. The 
(1’R)-1’,5’-anhydro-D-glucitol-spiro-[1’,5]-2-arylimidazolin-4-ones 152-155 proved to be 
weak inhibitors or showed no inhibition. The carbonyl group at the β-position is probably 
unfavourable in terms of the binding with the catalytic site and therefore the aromatic 
substituent does not fit to the β-channel in this orientation. 
 
Table 5: Inhibition of 1’,5’-anhydro-D-glucitol-spiro-[1’,5]-2-arylimidazolin-4-ones  
Structure Ki (µM) 
 Ar RMGPb RMGPa HLGPa 
 
Ph 152 135.5 
34.17 ± 
0.63 
119.11 ± 
6.15 
1-Naphthyl 153 
no inhibition 
(625 µM) 
653.78 ± 
18.08 
1173.67 ± 
36.92 
2-Naphthyl 154 
25 %  
(625 μM) 
212.39 ± 
15.94 
370.79 ± 
14.47 
4-CF3-Ph 155 
no inhibition 
(625 µM) 
- - 
 
Ph 156 8.97  
4.45 ± 
0.27 
8.43 ± 
0.41 
1-Naphthyl 157 12.98 
6.64 ± 
0.17 
22.24 ± 
0.90 
2-Naphthyl 158 2.14 
1.13 ± 
0.06 
1.72± 
0.07 
4-CF3-Ph 159 
no inhibition 
(625 µM) 
- - 
Inhibition constants (RMGPb) of previously synthetised spiro-hidantoins:
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 A similar phenomenon was also observed during the studies of the anomeric spiro-
hydantoins 76, 78. The (1’S)-1’,5’-anhydro-D-glucitol-spiro-[1’,5]-2-arylimidazolin-4-ones 
156-158 proved to be efficient inhibitors, although in contrast to our expectations they did not 
achieve outstanding inhibition. X-ray studies are not available yet, but it may be supposed that 
the imidazolinone ring may not be in the appropriate tautomeric form to establish hydrogen 
bond with the residue His377 of the enzyme.  
 The 3-β-D-glucopyranosyl-1,5-disubstituted-1,2,4-triazoles 191-199 were inactive (in 
625 µM concentration). Compared to the disubstituted-1,2,4-triazoles tested earlier that showed 
good inhibition, the additional substituent negatively affected the binding. In this case the 
heterocycle is unable to form H-bond with the enzyme and the unsuitable orientation of the 
substituent may prevent the tight binding. The disubstituted-1,2,4-triazoles 210-212 showed 
inhibitions, although the results were not outstanding (Table 6). In comparison with the 
inhibition constants of the C-β-D-glucosaminyl 1,2,4-triazoles 211, 212 with their 
glucopyranosyl counterparts (67, 68) the latter ones are more potent inhibitors. X-ray 
crystallography revealed that the structural basis of this difference in potency lies in the strength 
of the hydrogen bond interactions formed by the group at the 2′-position of the glucopyranose 
moiety with protein residues of the active site (N-H···X hydrogen bonds are known to be 
weaker than O-H···X ones).  
 
Table 6: Inhibition constants (RMGPb) of C-glucopyranosyl-1,2,4-triazoles 
Structure 
Ki (µM) 
 
Compound R R’ RMGPb RMGPa HLGPa 
210 OH 1-Naphthyl 11.50 ± 0.23 3.38 ± 0.28 8.91 ± 0.44 
211 NH2 Ph 35.2 ± 2.6 30.2 ± 2.2 30.8 ± 1.2 
212 NH2 2-Naphthyl 4.8 ± 0.35 5.3 ± 0.4 7.6 ± 0.1 
67* OH Ph 7 - 1.35 
68* OH 2-Naphthyl 0.41 - 0.172 
*Previously prepared compounds.  
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5. Possible application of the results 
In the course of my research, potential glycogen phosphorylase inhibitors were prepared. After 
further biological studies, the most efficient inhibitors may be applicable for the treatment of 
T2DM. In addition, they may also be useful for other diseases associated with glycogen 
metabolism (cardioprotective, antitumor activity). Recent research has shown that blood 
glucose levels can also be reduced by inhibition of type 2 sodium glucose cotransporter 
(SGLT2) in the kidney. Previously approved drugs are diarylmethane C-glycoside derivatives 
and the modification of these compounds may result in more potent SGLT2 inhibitors. The 
developed novel method for the preparation of 3-β-D-glucopyranosyl-1,5-disubstituted-1,2,4-
triazoles could be a useful synthetic pathway to obtain new C-glycosides. 
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